Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064

Condition:   Healthy Volunteers, Atopic Diathesis and Atopic Dermatitis Interventions:   Drug: LOU064;   Drug: Placebo Sponsor:   Novartis Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials